ANXA5 and acute myeloid leukemia: Interestingly, bromocriptine-treated AML cells were highly positive for the early apoptosis marker Annexin-V (Fig. 1b, Additional file 4: Figure S2A and data not shown), indicating that bromocriptine activated the cell death program in AML.